The analysis of different treatment methods for 184 cases of soft tissue sarcoma.
- Author:
Ying LUO
1
;
Zhang-Ding CHEN
;
Bing-Qiang HU
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Age Factors; Aged; Chemotherapy, Adjuvant; Child; Child, Preschool; Dermatofibrosarcoma; mortality; secondary; therapy; Female; Follow-Up Studies; Humans; Liposarcoma; mortality; secondary; therapy; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Retroperitoneal Neoplasms; mortality; pathology; therapy; Retrospective Studies; Skin Neoplasms; mortality; pathology; therapy; Soft Tissue Neoplasms; mortality; pathology; therapy; Survival Rate
- From: Chinese Journal of Oncology 2004;26(8):502-504
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the proper way of using combined postoperative chemo-radiotherapy and prognostic factors of soft tissue sarcoma.
METHODSThe clinical data of 184 patients were retrospectively reviewed. These patients were devided into surgery group (S, 94 patients), surgery plus postoperative radiotherapy group (S + R, 62 patients) and surgery plus chemotherapy group (S + C, 28 patients).
RESULTSThe 5-year survival rates of S, S + R and S + C groups were 39.4%, 48.4% and 28.6%, respectively. Combined multitherapy was the key to improve survival rate and life quality. Clinical stage, pathological type and therapeutic method were also important prognostic factors for the long term survival.
CONCLUSIONSurgery plus postoperative radiotherapy can improve the 5-year survival rate of soft tissue sarcoma.
